Immune effects of hormone replacement therapy in post-menopausal women

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

Stephen B. Hulley · JAMA · 1998 · 6.3K citations

Medicine, Endocrinology, Pharmacotherapy +17

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.

Séamus J. Martin, Chris Reutelingsperger, Anne J. McGahon et al. · The Journal of Experimental Medicine · 1995 · 2.9K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

The Lancet · 1997 · 2.5K citations · Full text

Medicine, Endocrinology, Oncology +15

Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk

Catherine Schairer · JAMA · 2000 · 1.1K citations

Medicine, Endocrinology, Oncology +12

Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males

René Zellweger, Matthias W. Wichmann, Alfred Ayala et al. · Critical Care Medicine · 1997 · 397 citations

Veterinary Medicine, Immunology, Pathobiology +16